Poster ARVO 2017 Baltimore USA
Real-world outcomes with ranibizumab 0.5 mg in treatment-naïve French patients with visual impairment due to diabetic macular edema: 12-month results from the ETOILE study
Eric Fourmaux, Amélie Lecleire-Collet,Corinne Dot,Marie-Laure Le Lez,Stéphanie Baillif,Ali Erginay,Eric Souied,Philippe Gain,Laetitia Finzi,Laurent Kodjikian
https://www.dropbox.com/s/qx0qintnwsbfbkx/Poster%20Etoile%20ARVO%202017.pdf?dl=0
